Tasian, S. K., Sabnis, H., Cooper, T. M., Sirvent, F. J. B., Petit, A., Kutny, M., Krieger, E., Schuettpelz, L. G., Kim, A., Borgman, A. E., Frankel, S., Butturini, A., Lu, L., Murray, K., Zwaan, C. M. (2025). A phase 1/2, open-label study evaluating the efficacy, safety, and pharmacokinetics of luveltamab tazevibulin in infants and children < 12 years of age with
            <i>CBFA2T3::GLIS2</i>
            acute myeloid leukemia.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps10074